Ignite Creation Date:
2024-05-06 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 2:29 PM
Study NCT ID:
NCT05318937
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2022-04-01
Brief Title:
A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinsons Disease Cognitive Impairment
Sponsor:
Sage Therapeutics
Organization:
Sage Therapeutics
Study Overview
Official Title:
A Randomized Double-blind Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Parkinsons Disease Cognitive Impairment
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Parkinsons disease mild cognitive impairment PD-MCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None